PPLO

(redirected from Mycoplasma pneumoniae)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.PPLO - a mycoplasma resistant to antibiotics that causes a kind of pneumonia in humans
mycoplasma - any of a group of small parasitic bacteria that lack cell walls and can survive without oxygen; can cause pneumonia and urinary tract infection
References in periodicals archive ?
Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia.
Since the early 2000s, macrolide-resistant Mycoplasma pneumoniae isolates have been identified in Japan.
SPLUNC1 has been shown to be a key role in promoting host innate immunity against Mycoplasma pneumoniae (Mp), and previous studies have verified in mouse.
2) Other bacterial causes of CAP include Moraxella catarrhalis, Staphylococcus aureus (typically occurring after influenza infection, and increasingly involving methicillin-resistant S aureus [MRSA]), and Group A streptococci, as well as the "atypical" bacterial pathogens: Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella species.
1] Although a number of different viral, bacterial, fungal and protozoan organisms can cause atypical pneumonia, the three most common are Chlamydia pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae.
They treated an 8-year-old girl diagnosed as having Henoch-Schonlein purpura (HSP) in combination with a mycoplasma pneumoniae infection using intravenous methylprednisolone (5 mg/kg/day) and erythromycin (30 mg/kg/day).
Although its pathogenetic mechanisms are far from being completely understood, EM is thought to be a hypersensitivity reaction to drugs (sulfonamides, anticonvulsants, antibiotics, antituberculous agents, and non-steroidal anti-inflammatory drugs), infections (herpes simplex virus 1 & 2, Mycoplasma pneumoniae, and various fungi) and vaccines (2).
The titer of Mycoplasma pneumoniae IgM antibodies was positive.
EM can be triggered by multiple causes: Ninety percent of cases are infectious, with herpes simplex virus infection the most common, followed by mycoplasma pneumoniae.
The agreement will benefit Labsystems Diagnostics and Oxford Biosystems leverage their respective leadership and long term experience in respiratory infectious diseases like Chlamydia pneumoniae, Mycoplasma pneumoniae and Bordetella pertussis.